{"organizations": [], "uuid": "779dd69955ec2eef30ba6754f2a27b05c0dc995f", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-proteostasis-receives-fda-fast-tra/brief-proteostasis-receives-fda-fast-track-designation-for-triple-combination-program-in-patients-with-cystic-fibrosis-idUSASC09UUD", "country": "US", "domain_rank": 408, "title": "BRIEF-Proteostasis Receives FDA Fast Track Designation For Triple Combination Program In Patients With Cystic Fibrosis", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.939, "site_type": "news", "published": "2018-04-04T18:10:00.000+03:00", "replies_count": 0, "uuid": "779dd69955ec2eef30ba6754f2a27b05c0dc995f"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-proteostasis-receives-fda-fast-tra/brief-proteostasis-receives-fda-fast-track-designation-for-triple-combination-program-in-patients-with-cystic-fibrosis-idUSASC09UUD", "ord_in_thread": 0, "title": "BRIEF-Proteostasis Receives FDA Fast Track Designation For Triple Combination Program In Patients With Cystic Fibrosis", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "fda", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "proteostasis therapeutics inc", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 4 (Reuters) - Proteostasis Therapeutics Inc:\n* PROTEOSTASIS THERAPEUTICS RECEIVES FDA FAST TRACK DESIGNATION FOR TRIPLE COMBINATION PROGRAM IN PATIENTS WITH CYSTIC FIBROSIS\n* ‍FDA GRANTED FAST TRACK DESIGNATION FOR CO’S TRIPLE COMBINATION PROGRAM FOR TREATMENT OF CYSTIC FIBROSIS​ Source text for Eikon: Further company coverage:\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-04-04T18:10:00.000+03:00", "crawled": "2018-04-04T13:21:48.009+03:00", "highlightTitle": ""}